Home » Topics » Regulatory

Regulatory
RSS

FDA approves Daurismo for newly diagnosed AML ineligible for intensive chemotherapy

Nov. 22, 2018

FDA grants accelerated approval to Venclexta for newly diagnosed AML

Nov. 22, 2018

FDA approves Gamifant for primary hemophagocytic lymphohistiocytosis

Nov. 21, 2018

FDA approves Aemcolo for the treatment of travelers' diarrhea

Nov. 19, 2018

FDA grants approval for Adcetris as first-line treatment for peripheral T-cell lymphoma

Nov. 19, 2018

European Commission approves Cabometyx for HCC previously treated with sorafenib

Nov. 15, 2018

FDA approves Yupelri for maintenance treatment of COPD

Nov. 12, 2018

European Commission approves expanded label for Trelegy Ellipta in COPD

Nov. 9, 2018

FDA approves Bijuva for moderate to severe hot flashes due to menopause

Oct. 30, 2018

France becomes first country to market baclofen preparation to reduce alcohol consumption

Oct. 29, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Sept. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Sept. 22, 2025.
The ‘molecular revolution’ driving R&D of new cancer therapeutics
BioWorld Asia
“New explosions in biotechnology are allowing us to interrogate cancers at a very sophisticated level compared to before,” Dennis Slamon told audience members at...
CHMP recommends EU approval of Bayer’s Lynkuet for hot flashes
BioWorld
Following the first approvals in the U.K., Canada, Australia and Switzerland, the EMA’s Committee for Medicinal Products for Human Use (CHMP) is now recommending...
Remynd’s REM-127 yields positive phase II data in Alzheimer’s
BioWorld
Remynd NV has turned in positive phase IIa data for a new target in Alzheimer’s disease, showing that restoring calcium homeostasis in neurons reduces levels of...